靶向抗凝蛋白S以改善血友病止血
研究探讨靶向蛋白S能否通过再平衡凝血促进血友病止血。血友病小鼠中靶向PS基因可防止出血,患者血浆中阻断PS使体外凝血酶生成正常化。PS和TFPIα在血友病小鼠关节中检测到,血友病A患者按需治疗时关节表达更强。
要点
- 血友病小鼠中靶向PS基因可防止出血,关节内尤其明显
- 阻断血友病患者血浆中的PS可使体外凝血酶生成正常化
- 血友病A患者按需治疗时关节PS和TFPI表达强于血友病B患者
核心结论
- 靶向PS可再平衡血友病凝血,PS抑制既是凝血调控因素也是潜在治疗靶点。
- 在小鼠中成功使用的PS沉默RNA方法可能构成血友病患者的新治疗概念。
研究设计与样本
- 研究在血友病小鼠中进行PS基因靶向,并在血友病患者血浆中进行体外实验。
- 检测了血友病小鼠关节中PS和TFPIα,并比较了血友病A与B患者关节中PS和TFPI表达。
主要发现
- 血友病小鼠中PS基因靶向保护其免于出血,关节内给药时尤其明显。
- 这些小鼠显示凝血酶生成增加、对活化蛋白C和TFPI抵抗以及纤维蛋白网络改善。
- 阻断血友病患者血浆中的PS使体外凝血酶生成正常化。
- 血友病A患者按需治疗时关节PS和TFPI表达强于血友病B患者。
- 接受凝血因子浓缩物预防治疗的血友病A患者关节PS和TFPI表达降低,与骨关节炎患者相当。
关键数值与推荐
- 血友病A和B影响全球40万人。
- PS作为活化蛋白C和TFPI的辅因子发挥抗凝作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Improved treatments are needed for hemophilia A and B, bleeding disorders affecting 400 000 people worldwide. We investigated whether targeting protein S could promote hemostasis in hemophilia by rebalancing coagulation. Protein S (PS) is an anticoagulant acting as cofactor for activated protein C and tissue factor pathway inhibitor (TFPI). This dual role makes PS a key regulator of thrombin generation. Here, we report that targeting PS rebalances coagulation in hemophilia. PS gene targeting in hemophilic mice protected them against bleeding, especially when intra-articular. Mechanistically, these mice displayed increased thrombin generation, resistance to activated protein C and TFPI, and improved fibrin network. Blocking PS in plasma of hemophilia patients normalized in vitro thrombin generation. Both PS and TFPIα were detected in hemophilic mice joints. PS and TFPI expression was stronger in the joints of hemophilia A patients than in those of hemophilia B patients when receiving on-demand therapy, for example, during a bleeding episode. In contrast, PS and TFPI expression was decreased in hemophilia A patients receiving prophylaxis with coagulation factor concentrates, comparable to osteoarthritis patients. These results establish PS inhibition as both controller of coagulation and potential therapeutic target in hemophilia. The murine PS silencing RNA approach that we successfully used in hemophilic mice might constitute a new therapeutic concept for hemophilic patients.
引用
- Prince R, Bologna L, Manetti M, et al. Targeting anticoagulant protein S to improve hemostasis in hemophilia. Blood. 2018. PMID: 29317453. doi:10.1182/blood-2017-09-800326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。